Antimicrobial susceptibility of Gram-positive bacteria: what's current, what's anticipated?

The Journal of hospital infection

Volumn 49 Suppl A, Issue , 2001, Pages S3-

  Johnson, A P ^a   Livermore, D M ^a   Tillotson, G S ^a  

^a CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; NEW DRUG; OXAZOLIDINONE DERIVATIVE; QUINUPRISTIN-DALFOPRISTIN; VIRGINIAMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CHEMISTRY; CLINICAL PRACTICE; CROSS INFECTION; EUROPE; HUMAN; INFECTION CONTROL; METHODOLOGY; REVIEW; UNITED STATES;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CHEMISTRY, PHARMACEUTICAL; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUGS, INVESTIGATIONAL; EUROPE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFECTION CONTROL; OXAZOLIDINONES; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES; VIRGINIAMYCIN;

MLCS; MLOWN;

EID: 0035754187     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0195-6701(01)90029-5     Document Type: Review

References (40)